NCT03110653View on ClinicalTrials.gov

Remifentanil and Hyperalgesia: Gradual Withdrawal Versus Immediate Discontinuation

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 15, 2017

Primary Completion Date

August 30, 2017

Study Completion Date

August 30, 2017

Conditions
AnesthesiaPain
Interventions
DRUG

Remifentanil

Remifentanil will be continued postoperatively, while being decreased (gradually by 30% every 15 mins)

DRUG

NaCl 0.9%

NaCl 0.9% will be administered postoperatively, while being decreased by 30% every 15 mins.

Trial Locations (1)

1070

Erasme Hospital, Brussels

All Listed Sponsors
lead

Université Libre de Bruxelles

OTHER

NCT03110653 - Remifentanil and Hyperalgesia: Gradual Withdrawal Versus Immediate Discontinuation | Biotech Hunter | Biotech Hunter